Ankur Drugs and Pharma Ltd has announced that the Board of Directors of the Company at its meeting held on November 13, 2009, inter alia, have issued and allotted 326119 Equity Shares of Rs 10/- each on conversion of 1000 FCCB of USD 1000.00 each at the conversion price of Rs 165/- inclusive of the accretion yield of 5% p. a., i.e. 48048 equity shares of Rs 10 each, from the date of issue till the receipt of notice of conversion, to Merrill Lynch Capital Markets Espana S. A. SV, Edificio Torre Picasso, Plaza Pablo Ruiz Picasso s/n 28020 Madrid (Bondholder}.
The stock was trading at Rs.202.50, up by Rs.2.75 or 1.38%. The stock hit an intraday high of Rs.203 and low of Rs.198.
The total traded quantity was 23007 compared to 2 week average of 39113.